Weitere Kongresshighlights

Neu im Programm: Symposium zur Palliativmedizin

Freitag 08.10.2010, 08:30 - 10:00 Uhr

Palliativmedizin - Vision oder Irrtum?
Vorsitz: F. Nauck (Göttingen), C. Müller-Busch (Berlin)

Themen:
Framework Sedierung - Schmerz als Sedierungsgrund?
Friedemann Nauck

SAPV - Aufgaben für den Schmerztherapeuten?
Christoph Ostgathe

Charta Palliativmedizin - Vision oder Irrtum?
Chrsitoph Müller-Busch

 

Eija Kalso



Wir freuen uns auf den Besuch der amtierenden IASP Präsidentin Eija Kalso beim Deutschen Schmerzkongress 2010 in Mannheim. Sie spricht am 08.10.2010 um 15 Uhr im Mozartsaal des CC Rosengarten unter dem Themenschwerpunkt "Visionen und Irrtümer" zum Thema:

Der Einfluss der pharmazeutischen Industrie auf die klinische Forschung und Meinungsbildung -Verwerflich, Nützlich oder Notwendig? Is there a Pharma Hype in Pain management?

Eija Kalso, M.D., D.Med. Sci is currently the Gyllenberg Professor of Pain Medicine and Vice Dean at the faculty of Medicine, University of Helsinki. She is president of IASP and field editor for clinical science in Pain.

She graduated from the Medical School of the University of Helsinki in 1980, defended her thesis on "Nerve Blocking Properties and Toxicity of Bupivacaine in Spinal and Intravenous Regional Anaesthesia in 1983 and became specialist in  anaesthesiology in 1986. She was appointed as associate professor in
anaesthesiology in 1992, University of Helsinki. She received special competence in pain management in 1999. She has worked as a post doc at the Nuffield Department of Anaesthetics, University of Oxford, with Sir Keith Sykes and professor Henry McQuay, and at the University College London, with professor Anthony Dickenson. She has also worked as a clinical teacher in anaesthesiology at the Karolinska Institute, Stockholm, Sweden.

Dr. Kalso is former president of the Scandinavian Association for the Study of Pain (SASP) and past founding president of the Finnish Association for the Study of Pain (FASP).

Dr. Kalsos main interests in research include opioid pharmacology, spinal mechanisms of nociception, cancer pain, clinical trial design and EBM, chronic postsurgery pain and more recently, genetics of pain.